Trials / Completed
CompletedNCT01492699
Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder
Single Site, Open Label Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Alachua Government Services, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study for adult subjects with Post Traumatic Stress Disorder.
Detailed description
Open label clinical study to evaluate the efficacy of PRX-03140 in reducing PTSD symptoms
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRX-03140 | 50 mg PRX-03140 capsules once daily for 2 weeks. After 2 weeks, the dose will increase to 100mg PRX-03140 once daily for 10 weeks. |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2011-12-15
- Last updated
- 2014-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01492699. Inclusion in this directory is not an endorsement.